Report Detail
Global (United States, European Union and China) Pandemic Influenza Vaccine Market Research Report 2019-2025
- RnM3669988 |
- 14 August, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Influenza vaccines treat influenza by developing antibodies in the body within two weeks after vaccination. These antibodies protect against infections with the help of the attenuated viruses in the vaccine. These vaccines contain killed or inactivated strains of the influenza virus.
In 2019, the market size of Pandemic Influenza Vaccine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Pandemic Influenza Vaccine.
This report studies the global market size of Pandemic Influenza Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Pandemic Influenza Vaccine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
AstraZeneca
GlaxoSmithKline
Novartis
Sanofi
Valneva
Lupin
Chiron Panacea
Solvay and Serum Institute of India Pvt. Ltd.
Sementis
Market Segment by Product Type
Influenza A (H1N1) Vaccines
Other
Market Segment by Application
Adult
Paediatric
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Pandemic Influenza Vaccine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Pandemic Influenza Vaccine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Pandemic Influenza Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Influenza A (H1N1) Vaccines
- 1.3.3 Other
- 1.4 Market Segment by Application
- 1.4.1 Global Pandemic Influenza Vaccine Market Share by Application (2019-2025)
- 1.4.2 Adult
- 1.4.3 Paediatric
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Pandemic Influenza Vaccine Market Size
- 2.1.1 Global Pandemic Influenza Vaccine Revenue 2014-2025
- 2.1.2 Global Pandemic Influenza Vaccine Sales 2014-2025
- 2.2 Pandemic Influenza Vaccine Growth Rate by Regions
- 2.2.1 Global Pandemic Influenza Vaccine Sales by Regions 2014-2019
- 2.2.2 Global Pandemic Influenza Vaccine Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Pandemic Influenza Vaccine Sales by Manufacturers
- 3.1.1 Pandemic Influenza Vaccine Sales by Manufacturers 2014-2019
- 3.1.2 Pandemic Influenza Vaccine Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Pandemic Influenza Vaccine Revenue by Manufacturers (2014-2019)
- 3.2.2 Pandemic Influenza Vaccine Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Pandemic Influenza Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.3 Pandemic Influenza Vaccine Price by Manufacturers
- 3.4 Key Manufacturers Pandemic Influenza Vaccine Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Pandemic Influenza Vaccine Market
- 3.6 Key Manufacturers Pandemic Influenza Vaccine Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Influenza A (H1N1) Vaccines Sales and Revenue (2014-2019)
- 4.1.2 Other Sales and Revenue (2014-2019)
- 4.2 Global Pandemic Influenza Vaccine Sales Market Share by Type
- 4.3 Global Pandemic Influenza Vaccine Revenue Market Share by Type
- 4.4 Pandemic Influenza Vaccine Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Pandemic Influenza Vaccine Sales by Application
6 United States
- 6.1 United States Pandemic Influenza Vaccine Breakdown Data by Company
- 6.2 United States Pandemic Influenza Vaccine Breakdown Data by Type
- 6.3 United States Pandemic Influenza Vaccine Breakdown Data by Application
7 European Union
- 7.1 European Union Pandemic Influenza Vaccine Breakdown Data by Company
- 7.2 European Union Pandemic Influenza Vaccine Breakdown Data by Type
- 7.3 European Union Pandemic Influenza Vaccine Breakdown Data by Application
8 China
- 8.1 China Pandemic Influenza Vaccine Breakdown Data by Company
- 8.2 China Pandemic Influenza Vaccine Breakdown Data by Type
- 8.3 China Pandemic Influenza Vaccine Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Pandemic Influenza Vaccine Breakdown Data by Company
- 9.2 Rest of World Pandemic Influenza Vaccine Breakdown Data by Type
- 9.3 Rest of World Pandemic Influenza Vaccine Breakdown Data by Application
- 9.4 Rest of World Pandemic Influenza Vaccine Breakdown Data by Countries
- 9.4.1 Rest of World Pandemic Influenza Vaccine Sales by Countries
- 9.4.2 Rest of World Pandemic Influenza Vaccine Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 AstraZeneca
- 10.1.1 AstraZeneca Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Pandemic Influenza Vaccine
- 10.1.4 Pandemic Influenza Vaccine Product Introduction
- 10.1.5 AstraZeneca Recent Development
- 10.2 GlaxoSmithKline
- 10.2.1 GlaxoSmithKline Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Pandemic Influenza Vaccine
- 10.2.4 Pandemic Influenza Vaccine Product Introduction
- 10.2.5 GlaxoSmithKline Recent Development
- 10.3 Novartis
- 10.3.1 Novartis Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Pandemic Influenza Vaccine
- 10.3.4 Pandemic Influenza Vaccine Product Introduction
- 10.3.5 Novartis Recent Development
- 10.4 Sanofi
- 10.4.1 Sanofi Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Pandemic Influenza Vaccine
- 10.4.4 Pandemic Influenza Vaccine Product Introduction
- 10.4.5 Sanofi Recent Development
- 10.5 Valneva
- 10.5.1 Valneva Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Pandemic Influenza Vaccine
- 10.5.4 Pandemic Influenza Vaccine Product Introduction
- 10.5.5 Valneva Recent Development
- 10.6 Lupin
- 10.6.1 Lupin Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Pandemic Influenza Vaccine
- 10.6.4 Pandemic Influenza Vaccine Product Introduction
- 10.6.5 Lupin Recent Development
- 10.7 Chiron Panacea
- 10.7.1 Chiron Panacea Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Pandemic Influenza Vaccine
- 10.7.4 Pandemic Influenza Vaccine Product Introduction
- 10.7.5 Chiron Panacea Recent Development
- 10.8 Solvay and Serum Institute of India Pvt. Ltd.
- 10.8.1 Solvay and Serum Institute of India Pvt. Ltd. Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Pandemic Influenza Vaccine
- 10.8.4 Pandemic Influenza Vaccine Product Introduction
- 10.8.5 Solvay and Serum Institute of India Pvt. Ltd. Recent Development
- 10.9 Sementis
- 10.9.1 Sementis Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Pandemic Influenza Vaccine
- 10.9.4 Pandemic Influenza Vaccine Product Introduction
- 10.9.5 Sementis Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Pandemic Influenza Vaccine Sales Channels
- 11.2.2 Pandemic Influenza Vaccine Distributors
- 11.3 Pandemic Influenza Vaccine Customers
12 Market Forecast
- 12.1 Global Pandemic Influenza Vaccine Sales and Revenue Forecast 2019-2025
- 12.2 Global Pandemic Influenza Vaccine Sales Forecast by Type
- 12.3 Global Pandemic Influenza Vaccine Sales Forecast by Application
- 12.4 Pandemic Influenza Vaccine Forecast by Regions
- 12.4.1 Global Pandemic Influenza Vaccine Sales Forecast by Regions 2019-2025
- 12.4.2 Global Pandemic Influenza Vaccine Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Pandemic Influenza Vaccine. Industry analysis & Market Report on Pandemic Influenza Vaccine is a syndicated market report, published as Global (United States, European Union and China) Pandemic Influenza Vaccine Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Pandemic Influenza Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
